首页> 外文会议>World congress on breast diseases >The expression of COX-2 and TRX-1 in breast cancer and the correlation with prognosis
【24h】

The expression of COX-2 and TRX-1 in breast cancer and the correlation with prognosis

机译:乳腺癌中COX-2和TRX-1的表达及与预后的相关性

获取原文

摘要

@@Introduction:Many studies indicated that over-expression of cyclooxygenase-2 (COX-2) was correlated with occurrence and development of many solid cancers (such as colorectal cancer, lung cancer, ect.). Over-expression of COX-2 protein in cancers was likely to occur via several different mechanisms involving complex signaling pathways. Over-expression had been associated with a poor clinical outcome. High incidence rates of over-expression COX-2 was also found in breast cancer patients. At present although we used selective inhibitor to improve prognosis, the angiomyocardiac adverse effect constrained the serviceable range. Furthermore the curative effect was not sure. So if we could inhibit expression of upstream control factors, it would be better for downregulation of COX-2. But now the mechanism of regulation was not clear.
机译:@@介绍:许多研究表明,环氧氧酶-2(COX-2)的过表达与许多固体癌症的发生和发育(如结肠癌,肺癌,等)相关。通过涉及复杂信号通路的几种不同机制,可能发生癌症中COX-2蛋白的过表达。过表达与临床结果不良有关。在乳腺癌患者中也发现过表达COX-2的高发率。目前,虽然我们使用选择性抑制剂来改善预后,但血管肌动脉的不良反应受到可维修范围。此外,疗效不确定。因此,如果我们能够抑制上游控制因素的表达,那么COX-2的下调将会更好。但现在规定的机制尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号